VISM
🇦🇺 ASX
NULL GLOBAL
NULL EX AUSTRALIA
NULL BETA
👑 Overview
📈 Performance
📙 Holdings
💰 Distributions
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💰
4.95%
Annual distribution yield
Based on the most recent distribution
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
221
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
VISM.AX was created on 2018-10-24 by Vanguard. The fund's investment portfolio concentrates primarily on small cap equity. The Vanguard MSCI International Small Companies Index ETF seeks to track the return of the MSCI World ex-Australia Small Cap Index in Australian dollars, before taking into account fees, expenses and tax.
📈 Performance
Price History
+14.06%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →📙 Top Holdings
Show moreUpdated as of 30 November 2022
Industry Exposure
🏭 Industrials
19%
🏦 Financials
15%
🛍️ Consumer
13%
🤖 Information
11%
🩺 Health
11%
🏡 Real Estate
9%
🧱 Materials
7%
🔋 Energy
5%
📙 Other
5%
⚡️ Utilities
3%
📞 Communication
3%
Country Exposure
🇺🇸 United States of America (the)
61%
🇯🇵 Japan
11%
🇬🇧 United Kingdom of Great Britain and Northern Ireland (the)
6%
🇨🇦 Canada
4%
🇸🇪 Sweden
2%
🇨🇭 Switzerland
2%
🇩🇪 Germany
2%
🇫🇷 France
1%
🇮🇹 Italy
1%
🇮🇱 Israel
1%
🇸🇬 Singapore
1%
🇳🇱 Netherlands (the)
1%
🇧🇲 Bermuda
1%
🇩🇰 Denmark
1%
🇪🇸 Spain
1%
🇳🇴 Norway
1%
🇭🇰 Hong Kong
1%
🇫🇮 Finland
1%
🇧🇪 Belgium
1%
💰 Distributions
Payouts
💰 Annual Distribution Yield*
4.95%
💰 Annual Distribution Earnings Per $1,000 invested**
$49.47
💰 Most Recent Distribution Franked Percentage Estimate
0.00%
💰 Average Distribution Franked Percentage Estimate
0.00 %
💰 Distribution reinvestment
* Based on the most recent distribution
** Calculated by multiplying the most recent distribution yield by $1,000
Distribution History
1Y
5Y
10Y
Graph
Table
Year
Yearly Distribution Earnings Per Share
Franking Estimate
2025
$0.00
0.00%
2024
$0.00
0.00%
2023
$1.16
0.00%
2022
$3.19
0.00%
2021
$3.28
0.00%
2020
$2.03
0.00%
2019
$2.20
0.00%
2018
$0.00
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
💵 Costs
💼
0.32%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$56.38
💰 Price To Earnings Ratio
12.09
💰 Price To Book Ratio
1.75
💰 Leveraged
No
💰 Inverse
No
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in VISM
221
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in VISM
677 days
VISM investor breakdown
💵 Income of investors
More than 200k
150k - 200k
7%
100k - 150k
20%
50k - 100k
43%
Less than 50k
24%
👶 Age of investors
18 - 25
14%
26 - 34
51%
35 - 90
36%
🙋 Legal gender of investors
Female
44%
Male
56%
Pearlers who invest in VISM also invest in...
VGE.AX was created on 2013-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Seeks to track the return of the FTSE Emerging Markets All Cap China A Inclusion Index in Australian dollars, before taking into account fees, expenses and tax.
📊 Share price
$67.24 AUD
NULL OTHER
NULL EX AUSTRALIA
NULL EMERGING
NULL BETA
VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax
📊 Share price
$73.26 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL EX AUSTRALIA
VETH.AX was created on 2020-10-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious Australian Shares ETF seeks to track the return ofthe FTSE Australia 300 Choice Index before taking into account fees, expenses and tax.
📊 Share price
$56.33 AUD
NULL AUSTRALIA
NULL ETHICAL
NULL SUSTAINABLE
NULL GREEN
IMPQ.AX was created on 2021-09-29 by eInvest. The fund's investment portfolio concentrates primarily on total market equity. The objective of the Fund is to deliver long-term capital growth predominately through investments in Australian and New Zealand listed smaller and mid-cap companies that are Better Future Investments.
📊 Share price
$4.98 AUD
NULL AUSTRALIA
NULL OTHER
NULL NEW ZEALAND
NULL SMART BETA
NULL ETHICAL
NULL THEMATIC
NULL ACTIVE
NULL IMPACT
CLNE.AX was created on 2021-03-08 by VanEck. The fund's investment portfolio concentrates primarily on theme equity. Each Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
📊 Share price
$8.71 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL SUSTAINABLE
NULL GREEN
Want more shares? Try these...
Vitura Health Ltd. operates as a medicinal cannabis company. The firm through its wholly owned subsidiary, CDA Health Pty Ltd, operates businesses, such as Burleigh Heads Cannabis and CDA Clinics. Burleigh Heads Cannabis operates the prescriber, patient, pharmacy and supplier online platform, CanView, which sells and distributes approximately 200 product stock-keeping units (SKUs) within Australia from 30 international and domestic medicinal cannabis producers. CDA Clinics undertakes telehealth consultations with patients seeking access to medicinal cannabis. Its portfolio of brands includes CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc and Adaya. The firm owns 75.5% of Cannadoc Health Pty Ltd, a medicinal cannabis clinic business that undertakes nationwide telehealth consultations with patients seeking access to medicinal cannabis.
📊 Share price